Stock Financial Ratios


CLRB / Cellectar Biosciences, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price1.50
Volume28,700.00
Market Cap ($M)19.80
Enterprise Value ($M)-0.74
Book Value ($M)13.54
Book Value / Share2.98
Price / Book2.64
NCAV ($M)13.69
NCAV / Share3.02
Price / NCAV2.61
Income Statement (mra) ($M)
Revenue0.00
EBITDA-9.45
Net Income-6.18
Balance Sheet (mrq) ($M)
Cash & Equivalents5.66
Cash / Share1.25
Assets9.87
Liabilities2.28
Quick Ratio7.47
Current Ratio7.47
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.46
Return on Assets (ROA)-0.40
Return on Equity (ROE)-0.46
Identifiers and Descriptors
CUSIP15117F302
Central Index Key (CIK)1279704
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
15117F203
Share Statistics
Common Shares Outstanding (M)15.81
Scoring Models
Piotroski F Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Raw Materials Per Share0.00
Liabilities And Stock Equity Per Share2.18
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Liabilities Per Share0.50
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Property Plant And Equipment Net Per Share0.33
Assets Per Share2.18
Equity Per Share1.67
Cash And Equivalents Per Share1.25
Inventory Work In Progress Per Share0.00
Long Term Debt Per Share0.00
Liabilities Current Per Share0.47
Treasury Stock Per Share0.00
Debt Per Share0.00
Assets Current Per Share1.47
Inventory Per Share0.00
Goodwill Per Share0.37
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Property Plant And Equipment Per Share0.33
Additional Paid In Capital Per Share19.37
Retained Earnings Per Share-17.69
Accumulated Depreciation And Depletion Per Share0.00
Cash Per Share1.25
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00

Related News Stories

Cellectar Biosciences' (CLRB) CEO Jim Caruso on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good day, ladies and gentlemen and welcome to the Cellectar Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. (43-0)

BRIEF-Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics

2017-09-21 reuters
* Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics to develop new phospholipid drug conjugates (43-0)

Cellectar Biosciences' (CLRB) CEO Jim Caruso on Q2 2017 Results - Earnings Call Transcript

2017-08-15 seekingalpha
Good day, ladies and gentlemen and welcome to the Cellectar Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]

CUSIP: 15117F302